Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease
Phase 1
Recruiting
- Conditions
- HyperuricemiaHypouricemia, Renal
- Interventions
- Other: Placebo matching IG3018
- First Posted Date
- 2024-03-15
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Intelligem Therapeutics Australia Pty Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT06310967
- Locations
- 🇦🇺
Emeritus Research Pty Ltd -Sydney, Botany, New South Wales, Australia
🇦🇺Pendlebury Research Pty Ltd T/A Novatrials, Kotara, New South Wales, Australia
🇦🇺Emeritus Research Pty Ltd -Melbourne, Camberwell, Victoria, Australia
News
No news found